Market News
Stay updated with the latest market trends, earnings, and economic indicators.
Sensex Today | Stock Market LIVE Updates: GIFY Nifty hints at gap-down; Ashok Leyland in focus
Sensex Today | Stock Market LIVE Updates: Brent continues to remain below $100 a barrel and the bulls would take that with both hands. For levels, 24,000 continues to act as a barrier for the index, while a close above 23,800 will be crucial to head into the new month on a positive note.
Mphasis to Glenmark - Jay Thakkar suggests 3 stocks to buy or sell for short-term in F&O segment
The Indian stock market is set to open lower, with the Gift Nifty at 23,882, down 97 points. Benchmark indices fell on profit-taking and rising crude oil prices, leading to cautious sentiment. Nifty 50 faces immediate hurdles at 24,100 and support at 23,800.
Trade Setup for May 27: Nifty holds on to key levels as market moves from one expiry to another
The Nifty Bank was the key contributor in the Nifty exhibiting sluggish moves on expiry day, but unlike the Nifty, the banking index continued to trade in a broad range. Despite a 500-point fall from the day's high, the index managed to hold on to the 55,000 mark on a closing basis, something the bulls could take heart from. Tuesday's high of 55,536 will be the first level to watch on the upside.
Stock Market Highlights: Sensex ends 479 pts lower, Nifty below 23,950; TechM, Apollo Hospitals drop 2% each - The Economic Times
Stock Market Highlights: Sensex ends 479 pts lower, Nifty below 23,950; TechM, Apollo Hospitals drop 2% eachThe Economic Times
Blue Jet Healthcare gains 8% post Q4; analysts split on near-term prospects
Emkay Global has retained its 'Reduce' rating, while Motilal Oswal has maintained its 'Buy' stance, reflecting contrasting expectations on recovery in key business segments and the margin trajectory
Healthcare, engineering and specialty chemicals remain key market themes: Mayuresh Joshi
Mayuresh Joshi, Director Research at Marketsmith India, believes execution will remain key for companies like Suzlon, while healthcare, engineering and select speciality chemical names continue to offer strong growth opportunities. He also sees India-focused engineering and capital goods companies remaining resilient despite global uncertainties. Joshi says investors should stay selective in IT, remains positive on Navin Fluorine, and is closely tracking niche AI-linked opportunities emerging in smaller tech firms.
Shares to buy or sell: Chandan Taparia of Motilal Oswal recommends three stocks to buy today - 26 May 2026 - Mint
Shares to buy or sell: Chandan Taparia of Motilal Oswal recommends three stocks to buy today - 26 May 2026Mint
Sun Pharma Shares In Focus As Motilal Oswal Retains Bullish Call After Q4 — Check Target Price, Upside
Sun Pharma delivered in-line revenue in Q4, whereas Ebitda/PAT came in lower than expected, dragged down by higher marketing spending and lower milestone income.
Ahead of Market: 10 things that will decide stock market action on Monday
Indian equity benchmarks closed modestly higher on Friday, with financial stocks leading the gains. The Nifty and Sensex edged up, though pharma and healthcare weakness capped the rise. Analysts noted the market's indecisive range-bound movement, awaiting a decisive breakout above 23,800 for further upward momentum or a fall towards 23,600.
Cotec Healthcare, Deepa Jewellers receive SEBI's nod to float IPOs
Cotec Healthcare and Deepa Jewellers get SEBI approval for IPOs, plan fresh issues and OFS to fund capacity expansion, working capital and general corporate needs, to list on BSE and NSE
Sensex today | Stock Market Live: Sensex drops day's gain, Nifty near 23,700; Max Health, Sun Pharma top losers - BusinessLine
Sensex today | Stock Market Live: Sensex drops day's gain, Nifty near 23,700; Max Health, Sun Pharma top losersBusinessLine
Stock Market News Today LIVE Updates: Nifty, Sensex Off Day's High In Last-Hour Trade; Aurobindo Pharma, Engineers India Slump Up To 9% - NDTV Profit
Stock Market News Today LIVE Updates: Nifty, Sensex Off Day's High In Last-Hour Trade; Aurobindo Pharma, Engineers India Slump Up To 9%NDTV Profit